News
Discover how simple lifestyle changes — like exercise, diet, and better sleep — can help reduce symptoms and improve quality ...
Patients with uveitis had a higher risk for psoriatic arthritis and psoriasis, whereas those with psoriatic arthritis had a higher risk for uveitis.
Among patients with PsA, MetS is associated with certain degenerative changes in the spine and entheses but not with peripheral or axial radiographic damage.
CHENNAI: India’s largest drug maker, Sun Pharmaceutical Industries, has completed its acquisition of US-based Checkpoint Therapeutics for approximately $355 mil ...
If you have psoriatic arthritis (PsA) and you’re having trouble falling or staying asleep, you’re not alone. As frustrating as it can be to toss and turn at night, this doesn’t have to be ...
Discover the top stock picks by market experts Raja Venkatraman, MarketSmith India, Ankush Bajaj and Trade Brains for ...
Indian equity markets recovered on Thursday after falling for two consecutive sessions. The BSE Sensex rose by 320.70 points ...
Misinterpretation of MRI findings by clinicians focused on earlier intervention is leading to increased rates of ...
The 5 things you can do to loosen up ‘creaky knees’ – and when it’s a sign of something more serious
WHETHER it’s stiffness when sitting up from a chair or painful twinges when tackling the stairs, knee problems are a common health issue, affecting people of all ages. One knee-related ...
FDA approvals for new biosimilars like Starjemza and Hadlima enhance treatment options, addressing urgent needs for ...
Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.
The FDA has expanded the interchangeable designation for Yuflyma (adalimumab-aaty), a biosimilar to Humira, to include all presentations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results